Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Enhancing Provider Networks: Coventry's Quality Improvement Program
Optimize Your Provider Network Quality with Coventry's Improvement Program Today!
Rising PTSD claims, wider comp liabilities spotlight importance of treatment guidelines
Mental health experts say that adherence to guidelines for the diagnosis and treatment of PTSD is essential when treating affected workers.
Enlyte and Former Genex Leaders Reach Agreement to Create New IME Business
Enlyte and its Board of Directors have made the strategic decision to transfer its Independent Medical Examination (IME) business and more than 350 employees from Enlyte to the creation of a new, stand-alone IME company, Emperion, Inc. Emperion will be owned by Stone Point Capital, Enlyte’s current shareholder, through its Trident Funds and a management team led by former Genex executives.
Ask The Pharmacist: The Role of a Pharmacy and Therapeutics (P&T) Committee
A Pharmacy and Therapeutics (P&T) committee plays a crucial role in the realm of health care, particularly in the context of a workers’ compensation pharmacy benefit manager (PBM). This committee is comprised of health care professionals, such as physicians and pharmacists, who are responsible for evaluating and making decisions about the formulary—a continually updated list of medications covered by a prescription drug plan.
Classic Collision Licenses Mitchell Cloud Estimating for Use at All Locations
Mitchell and Classic Collision, LLC, one of the top four largest MSOs in the nation, today announced that they have signed a multi-year agreement. The enterprise licensing agreement gives all current and future Classic Collision locations access to Mitchell Cloud Estimating with Integrated Repair Procedures as well as the company’s Paintless Dent Repair (PDR) calculator.
Enlyte Launches NJ DPR+ to Support Auto Injury Claim Management in New Jersey
Initiative offers unique, fully integrated, comprehensive solution for national support of payer bill review workflows in New Jersey